Witnessing the stock’s movement on the chart, on Wednesday, Revolution Medicines Inc (NASDAQ: RVMD) set off with pace as it heaved 2.93% to $48.51, before settling in for the price of $47.13 at the close. Taking a more long-term approach, RVMD posted a 52-week range of $15.44-$51.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 11.11% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -36.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.47%. This publicly-traded company’s shares outstanding now amounts to $164.67 million, simultaneously with a float of $139.21 million. The organization now has a market capitalization sitting at $8.10 billion. At the time of writing, stock’s 50-day Moving Average stood at $45.12, while the 200-day Moving Average is $38.16.
Revolution Medicines Inc (RVMD) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Revolution Medicines Inc’s current insider ownership accounts for 16.66%, in contrast to 87.24% institutional ownership. According to the most recent insider trade that took place on Oct 14 ’24, this organization’s insider sold 16,666 shares at the rate of 49.49, making the entire transaction reach 824,804 in total value, affecting insider ownership by 264,408. Preceding that transaction, on Oct 11 ’24, Company’s Chief Operating Officer sold 50,000 for 50.34, making the whole transaction’s value amount to 2,517,055. This particular insider is now the holder of 132,320 in total.
Revolution Medicines Inc (RVMD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
Revolution Medicines Inc’s EPS increase for this current 12-month fiscal period is 12.47% and is forecasted to reach -3.85 in the upcoming year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Let’s observe the current performance indicators for Revolution Medicines Inc (RVMD). It’s Quick Ratio in the last reported quarter now stands at 15.42. The Stock has managed to achieve an average true range (ATR) of 1.86. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10950.15.
In the same vein, RVMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.65, a figure that is expected to reach -0.89 in the next quarter, and analysts are predicting that it will be -3.85 at the market close of one year from today.
Technical Analysis of Revolution Medicines Inc (RVMD)
Going through the that latest performance of [Revolution Medicines Inc, RVMD]. Its last 5-days volume of 1.2 million was inferior to the volume of 1.31 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 23.18% While, its Average True Range was 1.96.
Raw Stochastic average of Revolution Medicines Inc (RVMD) in the period of the previous 100 days is set at 82.85%, which indicates a major rise in contrast to 50.30% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.20% that was lower than 40.26% volatility it exhibited in the past 100-days period.
